This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development ...

EssilorLuxottica buys RetinAI to boost AI-powered eyecare and data analytics, accelerating innovation in visual health screening ...

Preserving trial integrity. Clinical trials are susceptible to timing. Delays in investigational product delivery can stall ...

EssilorLuxottica announces the acquisition of Ikerian AG, a health technology company, operating under the RetinAI brand, specializing in AI and data management in eyecare. This move reinforces the ...

At the same time, Sinocare's exclusive partner, A.Menarini Diagnostics s.r.l, showcased the co-branded GlucoMen® iCan CGM system at EASD. Menarini highlighted the iCan system's latest features and ...

KDIGO's new IgA nephropathy guideline shifts the treatment paradigm from supportive care alone to targeting the disease's immunologic nature.

BioCryst Pharmaceuticals, Inc. acquires Astria Therapeutics for ~$700M, aiming to bolster its HAE portfolio. Learn more about ...

ART26.12 Phase 1 Data Demonstrated No Safety Concerns, Predictable Linear Plasma Exposure, and Options for Dosing in Either Fed or Fasted Conditions ...

Eight new oncology approvals between July and September 2025 marked a pivotal quarter for cancer treatment[1], as cellular ...

In nursing homes, neonatal units, and ICU wards, researchers are racing to turn pain into something a camera or sensor can ...

Among MASLD patients with T2D, those with good long-term glycemic control showed slower liver stiffness progression compared ...

The AI tool offers precise alopecia assessment, improving accuracy and sensitivity over traditional methods like the SALT ...